Ciclopirox has been identified to be a powerful KDM4B inhibitor that diminishes the growth of neuroblastoma cells while having minimal impact on healthy nerve cells, suggesting that it could be employed to counter neuroblastoma [113]. This evidence concerns the gene KDM4B and neuroblastoma.